515 related articles for article (PubMed ID: 10539992)
1. SHV-type beta-lactamases.
Tzouvelekis LS; Bonomo RA
Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
[TBL] [Abstract][Full Text] [Related]
2. beta-Lactamases of increasing clinical importance.
Bush K
Curr Pharm Des; 1999 Nov; 5(11):839-45. PubMed ID: 10539991
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
4. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
[TBL] [Abstract][Full Text] [Related]
5. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
6. Probing active site chemistry in SHV beta-lactamase variants at Ambler position 244. Understanding unique properties of inhibitor resistance.
Thomson JM; Distler AM; Prati F; Bonomo RA
J Biol Chem; 2006 Sep; 281(36):26734-44. PubMed ID: 16803899
[TBL] [Abstract][Full Text] [Related]
7. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
8. Epidemic and endemic spread of Klebsiella pneumoniae producing SHV-5 beta-lactamase in Dubrava University Hospital, Zagreb, Croatia.
Bedenić B; Schmidt H; Herold S; Monaco M; Plecko V; Kalenić S; Katíc S; Skrlin-Subić J
J Chemother; 2005 Aug; 17(4):367-75. PubMed ID: 16167514
[TBL] [Abstract][Full Text] [Related]
9. Amino acid substitutions causing inhibitor resistance in TEM beta-lactamases compromise the extended-spectrum phenotype in SHV extended-spectrum beta-lactamases.
Randegger CC; Hächler H
J Antimicrob Chemother; 2001 May; 47(5):547-54. PubMed ID: 11328764
[TBL] [Abstract][Full Text] [Related]
10. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
Rotschafer JC; Ostergaard BE
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
[TBL] [Abstract][Full Text] [Related]
11. Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria.
Heritage J; M'Zali FH; Gascoyne-Binzi D; Hawkey PM
J Antimicrob Chemother; 1999 Sep; 44(3):309-18. PubMed ID: 10511397
[TBL] [Abstract][Full Text] [Related]
12. A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous.
Liakopoulos A; Mevius D; Ceccarelli D
Front Microbiol; 2016; 7():1374. PubMed ID: 27656166
[TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum plasmid-mediated beta-lactamases.
Sirot D
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
[TBL] [Abstract][Full Text] [Related]
14. Emergence and prevalence of beta-lactamase-producing Klebsiella pneumoniae resistant to cephems in Japan.
Muratani T; Kobayashi T; Matsumoto T
Int J Antimicrob Agents; 2006 Jun; 27(6):491-9. PubMed ID: 16701983
[TBL] [Abstract][Full Text] [Related]
15. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
16. Insight into the effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type beta-lactamase: a molecular dynamics study.
Baig MH; Sudhakar DR; Kalaiarasan P; Subbarao N; Wadhawa G; Lohani M; Khan MK; Khan AU
PLoS One; 2014; 9(12):e112456. PubMed ID: 25479359
[TBL] [Abstract][Full Text] [Related]
17. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
Helfand MS; Bethel CR; Hujer AM; Hujer KM; Anderson VE; Bonomo RA
J Biol Chem; 2003 Dec; 278(52):52724-9. PubMed ID: 14534312
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance.
Hujer AM; Hujer KM; Bonomo RA
Biochim Biophys Acta; 2001 May; 1547(1):37-50. PubMed ID: 11343789
[TBL] [Abstract][Full Text] [Related]
19. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams.
Gutmann L; Ferré B; Goldstein FW; Rizk N; Pinto-Schuster E; Acar JF; Collatz E
Antimicrob Agents Chemother; 1989 Jun; 33(6):951-6. PubMed ID: 2669628
[TBL] [Abstract][Full Text] [Related]
20. Ultrahigh resolution structure of a class A beta-lactamase: on the mechanism and specificity of the extended-spectrum SHV-2 enzyme.
Nukaga M; Mayama K; Hujer AM; Bonomo RA; Knox JR
J Mol Biol; 2003 Apr; 328(1):289-301. PubMed ID: 12684014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
